Details for Patent: 8,927,497
✉ Email this page to a colleague
Which drugs does patent 8,927,497 protect, and when does it expire?
Patent 8,927,497 protects VALTOCO and is included in one NDA.
This patent has seventy patent family members in twenty-eight countries.
Summary for Patent: 8,927,497
| Title: | Absorption enhancers for intranasal administration |
| Abstract: | A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug. The invention also provides compositions that enhance absorption of drugs via the oral, ocular, nasal, nasolacrimal, inhalation or pulmonary, oral cavity (sublingual or Buccal cell) or CSF delivery route of a patient, including but not limited to insulin, glucagon and exendin-4. |
| Inventor(s): | Maggio; Edward T. (San Diego, CA) |
| Assignee: | Aegis Therapeutics, LLC. (San Diego, CA) |
| Application Number: | 13/371,274 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 8,927,497
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | NASAL ADMINISTRATION OF DIAZEPAM FOR TREATMENT OF INTERMITTENT, STEREOTYPIC EPISODES OF FREQUENT SEIZURE ACTIVITY IN PATIENTS 6 YEARS OF AGE AND OLDER | ⤷ Sign Up | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | NASAL ADMINISTRATION OF DIAZEPAM FOR TREATMENT OF INTERMITTENT, STEREOTYPIC EPISODES OF FREQUENT SEIZURE ACTIVITY IN PATIENTS 6 YEARS OF AGE AND OLDER | ⤷ Sign Up | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | NASAL ADMINISTRATION OF DIAZEPAM FOR TREATMENT OF INTERMITTENT, STEREOTYPIC EPISODES OF FREQUENT SEIZURE ACTIVITY IN PATIENTS 6 YEARS OF AGE AND OLDER | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,927,497
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009329952 | ⤷ Sign Up | |||
| Australia | 2011317202 | ⤷ Sign Up | |||
| Australia | 2019217643 | ⤷ Sign Up | |||
| Australia | 2021254650 | ⤷ Sign Up | |||
| Australia | 2024201523 | ⤷ Sign Up | |||
| Brazil | 112020015646 | ⤷ Sign Up | |||
| Brazil | PI0923403 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
